Highlight Selection of Radiochemistry and Radiopharmacy Developments by Editorial Board

Overview

Journal EJNMMI Radiopharm Chem

Date 2023 Mar 23

PMID 36952073

Authors

Oliver C Kiss

Peter J H Scott

Martin Behe

Ivan Penuelas

Jan Passchier

Ana Rey

Marianne Patt

Silvio Aime

Amir Jalilian

Peter Laverman

Zhen Cheng

Alain Faivre Chauvet

Jonathan Engle

Frederik Cleeren

Hua Zhu

Johnny Vercouillie

Michael van Dam

Ming Rong Zhang

Lars Perk

Benjamin Guillet

Francisco Alves

Affiliations

Soon will be listed here.

Abstract

Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.

Main Body: This selection of highlights provides commentary on 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals.

Conclusion: Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field, and include new PET-labelling methods for C and F, the importance of choosing the proper chelator for a given radioactive metal ion, implications of total body PET on use of radiopharmaceuticals, legislation issues and radionuclide therapy including the emerging role of Tb.

Citing Articles

Can we use PET to quantify mu opioid receptors across the monkey brain, spinal cord and peripheral organs at the same time? Totally!.

Scott P Eur J Nucl Med Mol Imaging. 2024; 51(11):3267-3272.

PMID: 38822890 DOI: 10.1007/s00259-024-06778-8.

References

Sap J, Meyer C, Ford J, Straathof N, Durr A, Lelos M . [F]Difluorocarbene for positron emission tomography. Nature. 2022; 606(7912):102-108. DOI: 10.1038/s41586-022-04669-2. View

Ginj M, Zhang H, Waser B, Cescato R, Wild D, Wang X . Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors. Proc Natl Acad Sci U S A. 2006; 103(44):16436-41. PMC: 1618814. DOI: 10.1073/pnas.0607761103. View

Kinne R, Emmrich F, Freesmeyer M . Clinical impact of radiolabeled anti-CD4 antibodies in the diagnosis of rheumatoid arthritis. Q J Nucl Med Mol Imaging. 2011; 54(6):629-38. View

de Vries E, Elsinga P, Tsoumpas C . Will extended field-of-view PET/CT depopulate the graveyard of failed PET radiopharmaceuticals?. Cancer Imaging. 2022; 22(1):70. PMC: 9761966. DOI: 10.1186/s40644-022-00510-1. View

Clausen A, Christensen C, Christensen E, Cold S, Kristensen L, Hansen A . Development of a Cu-labeled CD4 T cell targeting PET tracer: evaluation of CD4 specificity and its potential use in collagen-induced arthritis. EJNMMI Res. 2022; 12(1):62. PMC: 9481863. DOI: 10.1186/s13550-022-00934-7. View

Pauwels E, Cleeren F, Tshibangu T, Koole M, Serdons K, Dekervel J . [F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [Ga]Ga-DOTATATE in neuroendocrine tumour patients. Eur J Nucl Med Mol Imaging. 2020; 47(13):3033-3046. DOI: 10.1007/s00259-020-04918-4. View

Borgna F, Haller S, Monne Rodriguez J, Ginj M, Grundler P, Zeevaart J . Combination of terbium-161 with somatostatin receptor antagonists-a potential paradigm shift for the treatment of neuroendocrine neoplasms. Eur J Nucl Med Mol Imaging. 2021; 49(4):1113-1126. PMC: 8921065. DOI: 10.1007/s00259-021-05564-0. View

Bartos L, Kunte S, Beumers P, Xiang X, Wind K, Ziegler S . Single-Cell Radiotracer Allocation via Immunomagnetic Sorting to Disentangle PET Signals at Cellular Resolution. J Nucl Med. 2022; 63(10):1459-1462. PMC: 9536696. DOI: 10.2967/jnumed.122.264171. View

Shegani A, Kealey S, Luzi F, Basagni F, do Mar Machado J, Ekici S . Radiosynthesis, Preclinical, and Clinical Positron Emission Tomography Studies of Carbon-11 Labeled Endogenous and Natural Exogenous Compounds. Chem Rev. 2022; 123(1):105-229. PMC: 9837829. DOI: 10.1021/acs.chemrev.2c00398. View

10.

De Man K, Van Laeken N, Schelfhout V, Fendler W, Lambert B, Kersemans K . F-PSMA-11 Versus Ga-PSMA-11 Positron Emission Tomography/Computed Tomography for Staging and Biochemical Recurrence of Prostate Cancer: A Prospective Double-blind Randomised Cross-over Trial. Eur Urol. 2022; 82(5):501-509. DOI: 10.1016/j.eururo.2022.05.010. View

11.

Paillas S, Ladjohounlou R, Lozza C, Pichard A, Boudousq V, Jarlier M . Localized Irradiation of Cell Membrane by Auger Electrons Is Cytotoxic Through Oxidative Stress-Mediated Nontargeted Effects. Antioxid Redox Signal. 2016; 25(8):467-84. PMC: 5028911. DOI: 10.1089/ars.2015.6309. View

12.

McNeil S, Van de Voorde M, Zhang C, Ooms M, Benard F, Radchenko V . A simple and automated method for Tb purification and ICP-MS analysis of Tb. EJNMMI Radiopharm Chem. 2022; 7(1):31. PMC: 9718904. DOI: 10.1186/s41181-022-00183-y. View

13.

Bsharat O, Doyle M, Munch M, Mair B, Cooze C, Derdau V . Aldehyde-catalysed carboxylate exchange in α-amino acids with isotopically labelled CO. Nat Chem. 2022; 14(12):1367-1374. DOI: 10.1038/s41557-022-01074-0. View

14.

Minnix M, Kujawski M, Poku E, Yazaki P, Wong J, Shively J . Improved Tumor Responses with Sequential Targeted α-Particles Followed by Interleukin 2 Immunocytokine Therapies in Treatment of CEA-Positive Breast and Colon Tumors in CEA Transgenic Mice. J Nucl Med. 2022; 63(12):1859-1864. PMC: 9730924. DOI: 10.2967/jnumed.122.264126. View

15.

Laszlo G, Orozco J, Kehret A, Lunn M, Huo J, Hamlin D . Development of [At]astatine-based anti-CD123 radioimmunotherapy for acute leukemias and other CD123+ malignancies. Leukemia. 2022; 36(6):1485-1491. PMC: 9177726. DOI: 10.1038/s41375-022-01580-7. View

16.

Raave R, Sandker G, Adumeau P, Jacobsen C, Mangin F, Meyer M . Direct comparison of the in vitro and in vivo stability of DFO, DFO* and DFOcyclo* for Zr-immunoPET. Eur J Nucl Med Mol Imaging. 2019; 46(9):1966-1977. PMC: 6647232. DOI: 10.1007/s00259-019-04343-2. View

17.

Mota F, Ruiz-Bedoya C, Tucker E, Holt D, De Jesus P, Lodge M . Dynamic F-Pretomanid PET imaging in animal models of TB meningitis and human studies. Nat Commun. 2022; 13(1):7974. PMC: 9800570. DOI: 10.1038/s41467-022-35730-3. View

18.

Chen Z, Chen J, Chen L, Yoo C, Rong J, Fu H . Imaging Leucine-Rich Repeat Kinase 2 In Vivo with F-Labeled Positron Emission Tomography Ligand. J Med Chem. 2022; 66(3):1712-1724. DOI: 10.1021/acs.jmedchem.2c00551. View

19.

Laferriere-Holloway T, Rios A, van Dam R . Detrimental impact of aqueous mobile phases on 18F-labelled radiopharmaceutical analysis radio-TLC. Anal Methods. 2022; 15(3):377-387. PMC: 9891729. DOI: 10.1039/d2ay01206e. View

20.

Pauwels E, Cleeren F, Tshibangu T, Koole M, Serdons K, Boeckxstaens L . F-AlF-NOTA-Octreotide Outperforms Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter Study. J Nucl Med. 2022; 64(4):632-638. DOI: 10.2967/jnumed.122.264563. View